Asteria Health recalled 7,840 testosterone pellets on January 26, 2026, due to potential metal particulate matter contamination. Consumers must stop using the product immediately and contact healthcare providers for guidance. The recall affects products distributed nationwide in the USA.
Presence of Foreign substance - potential presence of metal particulate matter
Consumers and healthcare providers should stop using this product immediately. Contact F.H. INVESTMENTS, Inc. (dba Asteria Health) or your healthcare provider for guidance. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
The product is a testosterone pellet used for hormone replacement therapy. Consumers buy it to manage low testosterone levels and related health issues.
The contamination risk arises from the potential presence of metal particles, which can cause serious health complications if ingested.
This recall is not part of a broader industry pattern.
Consumers must stop using the product immediately, which may interrupt their hormone therapy regimen. This could lead to health implications if alternative therapies are not arranged promptly.
Look for the lot number and expiration date on the product packaging, usually found on the label or bottom of the box.
Expect a refund or replacement process to take approximately 4-6 weeks after contacting the manufacturer.
Keep records of your purchase, any correspondence regarding the recall, and document the lot number and expiration date.
The recall involves testosterone pellets containing 200mg of testosterone and 40mcg of triamcinolone acetonide. The affected lot number is 256000105, expiring on September 19, 2026. The product is manufactured by F.H. INVESTMENTS, Inc. and was sold nationwide.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Asteria Health recalled 133 estradiol pellets on January 26, 2026, after detecting potential metal particulate matter. The recall, classified as Class II, affects pellets with lot number 253000126 and an expiration date of June 9, 2026. Consumers must stop using the product immediately and contact their healthcare provider for guidance.
Asteria Health recalled 60,868 testosterone pellets on January 26, 2026, due to contamination risks. The recall affects specific lots of the product that may contain metal particulate matter. Consumers must stop using the product immediately and seek guidance from healthcare providers.
Asteria Health recalled 1,015 testosterone pellets on January 26, 2026 due to potential metal particulate contamination. The recall affects products distributed nationwide in the United States. Consumers must stop using the pellets immediately and contact their healthcare provider for guidance.
Asteria Health recalled 89,074 testosterone pellets on January 26, 2026. The recall stems from potential metal particulate contamination. Consumers must stop using the product and contact their healthcare provider immediately.
Asteria Health recalled 22,478 Estradiol 12.5 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers and healthcare providers must stop using the product immediately. The FDA classified this recall as Class II, indicating a high hazard level.
Asteria Health recalled 24,099 Estradiol, 10 mg pellets on January 26, 2026, due to potential metal particulate contamination. Consumers should stop using the product immediately. The recall affects pellets distributed nationwide in the USA.
Asteria Health recalled 50,990 Estradiol pellets on January 26, 2026, due to potential metal particulate matter contamination. The recall affects products distributed nationwide in the USA. Consumers should stop using the pellets immediately and seek guidance from healthcare providers.
Asteria Health recalled 1,464 testosterone pellets on January 26, 2026, due to potential metal particulate contamination. The recall affects products distributed nationwide. Consumers must stop using the product immediately and seek guidance from healthcare providers.